BioProcessing Journal Posts

Downstream processing is increasingly seen to be a capacity constraint for many biopharmaceutical manufacturing organizations. In our current study, nearly 75% of respondents reported that their facilities were experiencing some degree of capacity bottlenecks as a result of downstream processing. In comparison, 63.8% responded the same in the previous year. As the biopharmaceutical industry increases its focus on cost containment, product pricing, and healthcare reform, critical manufacturing operations have been pushed to center stage. Over the past few years, downstream processing, which includes complex operations such as filtration of final products and chromatography operations has become increasingly challenging, from budgetary and operational perspectives. As upstream operations continue to improve, the ability of current downstream facilities to handle the additional load has led to strains and constrictions. The industry is open to new solutions although few alternatives to current processes have been presented. A number of promising innovative technologies are on the horizon, but it will be a few years or more before they debut in clinical or commercial production operations….

Manufacturing

The success of tissue-engineered cartilage constructs (TECCs) as treatment options for healing cartilage defects can only be achieved if suitable preservation methods are found that can maintain their viability and function. Simply lowering the temperature of cells and tissues to below their freezing point invariably destroys them due to ice crystals that form in the water-laden cells and tissues. In addition, high salt concentrations that result from removal of water due to ice formation create a toxic imbalance. If the formation of ice crystals can be minimized while still halting metabolic activity of cells at low temperatures, then the viability and functionality of the preserved tissue may be maintained…

Biologics Production

Viable cell density (VCD), the quantitative assessment of living cells, is commonly determined by laborious and inaccurate off-line cell counting methods. Single-function in situ probes have been developed using various technologies including optical density, radio frequency and dielectric permittivity. Optical density measurements predict total biomass but are sensitive to cell debris accumulation and inherent media turbidity. Near-infrared (NIR) has the advantage of being able to measure many key analytes in the cell culture simultaneously. NIR has been used to acquire real-time measurements of glucose, glutamine, glutamate, and media nutrients such as amino acids and metabolites (e.g., lactate and ammonia). NIR probes can be sterilized in place, and real-time measurements can be acquired throughout the mammalian cell culture processes…

Biologics Production

The lotus (Nelumbo nucifera) is a fresh-water plant that grows in semitropical climates. It is cultivated extensively in Asian countries, particularly in China. Besides its popularity as an ornamental flower, it is also used as an herbal medicine, mainly in China, Japan, and India, and it displays strong antipyretic, cooling, astringent, and demulcent properties. Lotus seed is widely used as a food in China. Lotus seed is rich in protein, amino acids, unsaturated fatty acids, and has adequate amounts of essential minerals such as potassium, calcium, magnesium, and iron, without heavy metal contamination. As a protein source, the crude protein of lotus seed is higher than parboiled rice (7.70%) and wheat (8.55%). Unlike legumes, lotus seed possesses adequate sulfuric amino acids (methionine + cysteine), comparable to the FAO/WHO and soybean reference patterns. The high content and high quality of protein in lotus seeds emphasizes their value as a vital source of nutrients…

Biologics Production Manufacturing

Heterologous expression of membrane proteins remains a bottleneck for structural characterization by x-ray crystallography. Such proteins represent approximately 30% of the proteome and are not sufficiently represented in the Protein Data Bank (PDB). G-protein-coupled receptors (GPCRs) are an area of particular interest as it is estimated that one third of current FDA approved drugs act through this class of receptors. We have been studying rhodopsin with an interest in determining the conformational change that leads to signal transduction in this class of receptors. Although there has been some success in expressing select members of the large GPCR family in bacterial systems, the best characterized expression systems have generally been in mammalian tissue culture…

Biologics Production

Cell substrates are used in various stages of viral vaccine manufacturing, as in the isolation, selection, and propagation of the virus seed or virus vector stock, as well as for the amplification of the virus to produce the final vaccine product. The various stages of cell substrate use, including cell banking, are shown in a generic manufacturing scheme in Figure 1. Traditionally, viral vaccines have been produced in animal tissues, primary cell cultures, and cell lines that either have a finite life span, such as normal diploid cells, or a theoretically infinite life span, as achieved with continuous or immortalized neoplastic cells. The cell substrates used in viral vaccines currently licensed in the US are listed in Table 1…

Manufacturing Viral Vectors

Monoclonal antibodies (mAb) are highly selective molecules, and an unlimited amount of mAbs with equal quality can be produced using mammalian cell cultures and animals. These molecules have remarkable applications in biomedicine, diagnosis and therapy due to the ability to reproduce exactly the same binding properties. The mAbs have been generated against an ostensible set of compounds such as toxins, drugs, blood proteins, cancer cells, viruses, hormones, environmental pollutants, food products, metals and plant materials. In general, mAbs can also be used for creating sensitive tests to detect small amounts of substances, and in therapies, abzymes, and for isolating specific compounds from complex mixtures by immunoaffinity chromatography (IAC)…

Manufacturing

Many laboratories have utilized cell-free systems or prokaryotic systems designed to produce biological molecules with single polypeptide chains, limited folding requirements, and without glycosylation. The yeast systems are used to generate glycoproteins; however, their glycosylation profiles are vastly different from those of mammalian cells. Without significant glycoengineering, the yeast-produced recombinant glycoproteins may be unsuitable as therapeutic molecules. As such, the use of mammalian cells is still the preferred method to produce complex biological molecules…

Biologics Production

Mass transfer is one of the most crucial parameters during scale-up in cell culture, and may cause variations in specific yields. At the cellular level, all the cells require proper supplementation of essential nutrient sources: nitrogen, oxygen, and carbon. The ability of cells to grow, maintain viability, and provide high specific productivity depends on the proper distribution of these nutrients. The latter depends on proper mass transfer to supply oxygen, carbon, and nitrogen through agitation and aeration, along with other micronutrients…

Manufacturing

Directed evolution has profoundly changed the way antibodies or antigen binding fragments (Fab) are produced today. Lead generation for product candidates is oftentimes based on complex combinatorial libraries containing a large collection of variant antibodies. The selection of candidate molecules by screening procedures like phage display is considered the gold standard. One major advantage of these methods is that initial candidate molecules can be further improved in terms of affinity, specificity, etc. by reiterative in vitro maturation processes using the very methods that have been used for lead generation…

Biologics Production